| Not Yet Recruiting | A Food Effect Study of VC005 Tablets in Healthy Adult Subjects. Atopic Dermatitis | Phase 1 | 2026-04-30 |
| Recruiting | Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. Active Ankylosing Spondylitis | Phase 3 | 2025-12-26 |
| Completed | Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild Atopic Dermatitis (AD) | Phase 1 | 2025-11-11 |
| Recruiting | Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo Non-segmental Vitiligo | Phase 2 | 2025-10-31 |
| Completed | Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal M Acute Coronary Syndrome | Phase 1 | 2025-08-05 |
| Completed | The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers Atopic Dermatitis | Phase 1 | 2025-05-26 |
| Completed | Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate A Atopic Dermatitis | Phase 2 | 2025-04-28 |
| Recruiting | Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors Locally Advanced Solid Tumor | Phase 3 | 2025-03-17 |
| Recruiting | Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis Moderate to Severe Atopic Dermatitis | Phase 3 | 2024-12-30 |
| Completed | A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsul Locally Advanced or Metastatic Solid Tumor | Phase 1 | 2024-09-18 |
| Recruiting | Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous C Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) | Phase 3 | 2024-09-06 |
| Completed | Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion | Phase 1 | 2024-07-22 |
| Completed | Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to M Atopic Dermatitis | Phase 1 | 2023-07-27 |
| Completed | Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatiti Moderate to Severe Atopic Dermatitis | Phase 2 | 2023-07-20 |
| Completed | A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis. Rheumatoid Arthritis | Phase 1 | 2023-06-12 |
| Completed | Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. Active Ankylosing Spondylitis | Phase 2 | 2023-04-26 |
| Unknown | Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects Healthy Subjects | Phase 1 | 2022-11-14 |
| Completed | Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion | Phase 1 | 2022-10-20 |
| Completed | Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects Inflammatory Bowel Diseases | Phase 1 | 2022-06-18 |
| Completed | PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers Acute Coronary Syndrome | Phase 1 | 2021-12-09 |
| Completed | Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects Inflammatory Bowel Diseases | Phase 1 | 2021-11-18 |
| Completed | A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects Acute Coronary Syndrome | Phase 1 | 2021-08-24 |
| Unknown | The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | 2020-11-20 |
| Completed | The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man Healthy Male Adult | Phase 1 | 2019-11-11 |
| Completed | Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19 Healthy Subjects, PK/PD | Phase 1 | 2019-04-03 |
| Completed | The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel Coronary Artery Disease, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors | Phase 2 | 2018-08-30 |